Private Trust CO Na Sarepta Therapeutics, Inc. Transaction History
Private Trust CO Na
- $964 Million
- Q3 2024
A detailed history of Private Trust CO Na transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 35 shares of SRPT stock, worth $4,343. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$4,343
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.28 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.11 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$777 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$541 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$530 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...